The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin

@inproceedings{EFFREY2000TheEO,
  title={The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin},
  author={EFFREY and K. B. and ROWNE and OAN and C. E.M. and GRIE and LLEN and R. N and ISSENSON and OUGLAS and M. O and KAMOTO and TEVE and J. S and CHWAB and AVID and A. G and OODKIN},
  year={2000}
}
  • EFFREY, B. K., +15 authors OODKIN
  • Published 2000
A BSTRACT Background In patients with end-stage renal disease, anemia develops as a result of erythropoietin deficiency, and recombinant human erythropoietin (epoetin) is prescribed to correct the anemia partially. We examined the risks and benefits of normalizing the hematocrit in patients with cardiac disease who were undergoing hemodialysis. Methods We studied 1233 patients with clinical evidence of congestive heart failure or ischemic heart disease who were undergoing hemodialysis: 618… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 21 times over the past 90 days. VIEW TWEETS